The clinical profile of end-stage AIDS

AIDS Patient Care and STDs

Volumn 12, Issue 2, 1998, Pages 125-129

  Welch, Kathleen ^a,c   Kissinger, Patricia ^b   Bessinger, Ruth ^b   Dascomb, Kristin ^b   Morse, Anne ^a   Gleckler, Elisbeth ^a  

^a Louisiana Office of Public Health   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; AZITHROMYCIN; CLARITHROMYCIN; COTRIMOXAZOLE; DAPSONE; DIDANOSINE; LAMIVUDINE; PENTAMIDINE; PROTEINASE INHIBITOR; RIFABUTIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DEMENTIA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIOSIS; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; PREVALENCE; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROPHYLAXIS; QUALITY OF LIFE; TERMINAL CARE; TOXOPLASMOSIS;

EID: 0031912121     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.1998.12.125     Document Type: Article

References (11)

1. AIDS cases, case-fatality rates, and deaths by half-year and age-group through June, 1996, United States, Centers for Disease Control and Prevention HIV AIDS Surveillance Report. 8(1):14, 1996.
2. Saah, A.J., Hoover, EX, Yanhua, H., Kingsley, A., Phair, J., et al. Factors influencing survival after AIDS: report from the Multicenter AIDS Cohort Study (MACS). J Acquir Immun Defic Synd 7:287-295, 1994.
3. Blum, S., Singh, T., Gibbons, J., Fordyce, E., Lessner, L., Chiasson, M., et al. Trends in survival among persons with acquired immunodeficiency syndrome in New York City. Am J Epidemiol 139(4):351-361, 1994.
4. Luo, K., Law, M., Kaldor, J., McDonald, A., Cooper, D. The role of initial AIDS-defined illness in survival following AIDS. AIDS 9:57-63, 1995.
5. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults, MMWR 41(RR-17):1-19, 1993.
6. Farizo, K.M., Buehler, J.W., Chamberland, M.E., et al. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA 267:1798-1805.
7. Moore, R., Chaisson, R. Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med 124(7):633-42, 1996.
8. Finkelstein, D., Williams, P., Molenberghs, G., Feinberg, J., Powderly, W., Kahn, J., et al. Patterns of opportunistic infections in patients with HIV Infection. J Acquir Immun Defic Syndr 12:138-145, 1996.
9. Chan, I., Neaton, J., Saravolatz, L., Crane, L., Osterberger, J. Frequencies of opportunistic diseases prior to death, among HIV-infected persons. AIDS 9:1145-1151, 1995.
10. Kotler, D.P. Cytomegalovirus colitis and wasting. J Acquir Immun Defic Syndr 4:536-41, 1991.
11. Lemoine, C., Gleckler, E. Hospice referrals for AIDS patients. Louisiana Office of Public Health HIV/AIDS Line (5):9, 1996.